Reduction in expenditures on analgesics during one year of treatment of chronic tension headache with BoNT-A

The aim of this study was to investigate the impact of the use of botulinum toxin type A (BoNT-A; BOTOX; Allergan, Inc.; Irvine, CA) as preventive treatment of chronic tension-type headache (CTH) on analgesic use and expenditure. This was a prospective, single-center, 1-year, open-label study of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Coloprisco, Gabriella, De Filippis, Sergio, Santi, Pier Giorgio, Fiore, Giuseppe, Rodio, Anna, Martelletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2003
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452140/
http://dx.doi.org/10.1007/s10194-003-0037-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452140/
http://dx.doi.org/10.1007/s10194-003-0037-6

Ejemplares similares